| Safety and immunogenicity of an inactivated severe acute respiratory syndrome coronavirus 2 vaccine in a subgroup of healthy adults in Chile SM Bueno, K Abarca, PA González, NMS Gálvez, JA Soto, LF Duarte, ... Clinical Infectious Diseases 75 (1), e792-e804, 2022 | 103 | 2022 |
| Recognition of variants of concern by antibodies and T cells induced by a SARS-CoV-2 inactivated vaccine F Melo-González, JA Soto, LA González, J Fernández, LF Duarte, ... Frontiers in immunology 12, 747830, 2021 | 76 | 2021 |
| Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial SM Bueno, K Abarca, PA González, NMS Gálvez, JA Soto, LF Duarte, ... MedRxiv, 2021 | 71 | 2021 |
| Immune profile and clinical outcome of breakthrough cases after vaccination with an inactivated SARS-CoV-2 vaccine LF Duarte, NMS Gálvez, C Iturriaga, F Melo-González, JA Soto, ... Frontiers in immunology 12, 742914, 2021 | 66 | 2021 |
| The role of dendritic cells during infections caused by highly prevalent viruses JA Soto, NMS Gálvez, CA Andrade, GA Pacheco, K Bohmwald, ... Frontiers in Immunology 11, 1513, 2020 | 61 | 2020 |
| Human metapneumovirus: mechanisms and molecular targets used by the virus to avoid the immune system JA Soto, NMS Gálvez, FM Benavente, MS Pizarro-Ortega, MK Lay, ... Frontiers in immunology 9, 2466, 2018 | 47 | 2018 |
| Recombinant BCG vaccines reduce pneumovirus-caused airway pathology by inducing protective humoral immunity JA Soto, NMS Gálvez, CA Rivera, CE Palavecino, PF Céspedes, ... Frontiers in immunology 9, 2875, 2018 | 46 | 2018 |
| Antibody development for preventing the human respiratory syncytial virus pathology JA Soto, NMS Gálvez, GA Pacheco, SM Bueno, AM Kalergis Molecular Medicine 26, 1-10, 2020 | 38 | 2020 |
| Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial K Abarca, E Rey-Jurado, N Muñoz-Durango, Y Vázquez, JA Soto, ... EClinicalMedicine 27, 2020 | 35 | 2020 |
| A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus E Rey-Jurado, J Soto, N Gálvez, AM Kalergis Human vaccines & immunotherapeutics 13 (9), 2092-2097, 2017 | 33 | 2017 |
| Current insights in the development of efficacious vaccines against RSV JA Soto, LM Stephens, KA Waldstein, G Canedo-Marroquín, SM Varga, ... Frontiers in immunology 11, 547662, 2020 | 31 | 2020 |
| Performance of the international classifications criteria for autoimmune hepatitis diagnosis in Mexican patients L Muñoz-Espinosa, G Alarcon, A Mercado-Moreira, P Cordero, ... Autoimmunity 44 (7), 543-548, 2011 | 29 | 2011 |
| A booster dose of CoronaVac increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern BM Schultz, F Melo-González, LF Duarte, NMS Gálvez, GA Pacheco, ... MBio 13 (4), e01423-22, 2022 | 27 | 2022 |
| Characterization of the anti-inflammatory capacity of IL-10-producing neutrophils in response to Streptococcus pneumoniae infection LA González, F Melo-González, VP Sebastián, OP Vallejos, LP Noguera, ... Frontiers in immunology 12, 638917, 2021 | 27 | 2021 |
| Peripheral blood classical monocytes and plasma interleukin 10 are associated to neoadjuvant chemotherapy response in breast cancer patients J Valdés-Ferrada, N Muñoz-Durango, A Pérez-Sepulveda, S Muñiz, ... Frontiers in immunology 11, 1413, 2020 | 24 | 2020 |
| BCG vaccination induces cross-protective immunity against pathogenic microorganisms JA Soto, NMS Gálvez, CA Andrade, MA Ramírez, CA Riedel, AM Kalergis, ... Trends in Immunology 43 (4), 322-335, 2022 | 23 | 2022 |
| Bacterial and viral coinfections with the human respiratory syncytial virus GA Pacheco, NMS Gálvez, JA Soto, CA Andrade, AM Kalergis Microorganisms 9 (6), 1293, 2021 | 23 | 2021 |
| Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection AE González, MK Lay, EL Jara, JA Espinoza, RS Gómez, J Soto, ... Virulence 8 (6), 685-704, 2017 | 23 | 2017 |
| Lung pathology due to hRSV infection impairs blood–brain barrier permeability enabling astrocyte infection and a long-lasting inflammation in the CNS K Bohmwald, JA Soto, C Andrade-Parra, A Fernández-Fierro, ... Brain, Behavior, and Immunity 91, 159-171, 2021 | 22 | 2021 |
| The Optimisation of the Expression of Recombinant Surface Immunogenic Protein of Group B Streptococcus in Escherichia coli by Response Surface Methodology … DA Diaz-Dinamarca, JI Jerias, DA Soto, JA Soto, NV Diaz, YY Leyton, ... Molecular biotechnology 60, 215-225, 2018 | 20 | 2018 |
Dr. Alexis KalergisFull Professor and Director. Millennium Institute on Immunology. P. Univ. Católica Chile.Verified email at bio.puc.cl
